Contestation. Nucryst shall not, during the Term of this Agreement or thereafter, dispute, contest or challenge, directly or indirectly, the validity or enforceability of any one or more of the World Wide Acticoat Trade-m▇▇▇ Rights, the World Wide Acticoat Registrations or the ownership thereof by S&N, nor to counsel, procure, or assist anyone else to do the same.
Appears in 2 contracts
Sources: License and Development Agreement (NUCRYST Pharmaceuticals Corp.), License and Development Agreement (NUCRYST Pharmaceuticals Corp.)